Boston Marriott Copley
Thirty-three states have legalized medicinal marijuana and ten states have legalized the adult use of marijuana. However, the Controlled Substances Act (Schedule One) and ongoing regulatory uncertainty presents a barrier to full realization of the potential of this $50+ billion business. This quickly developing sector affects virtually every area of the law and provides opportunities to those with the knowledge base to deftly guide clients and companies through a shifting regulatory and legal landscape. The DRI Cannabis Law Seminar provides you with subject-matter experts who will share with you the knowledge and strategies needed by professionals, businesses, and insurers to traverse the complex pitfalls and prospects of cannabis legalization successfully.